BIOMAT Database Logo BIOMAT Database Logo

Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy. 1987

E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study.
December 1982, American journal of clinical oncology,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
Phase I study of high-dose mitomycin with autologous bone marrow support.
February 1982, Cancer treatment reports,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
April 1996, Bone marrow transplantation,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trial.
April 1981, Blut,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study.
October 1995, Bone marrow transplantation,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma.
June 1990, Blood,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
High-dose cytoreductive therapy with autologous bone marrow transplantation in advanced malignancies.
February 1983, Cancer treatment reports,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study.
July 1996, Pediatric neurosurgery,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer.
May 1984, Cancer treatment reports,
E J Kanfer, and F B Petersen, and C D Buckner, and P Stewart, and R Storb, and R S Hill, and F R Appelbaum, and R A Clift, and K C Doney, and H M Shulman
Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
June 1995, Blood,
Copied contents to your clipboard!